Alyssa Levin
Directeur Financier/CFO chez NKARTA, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Alyssa Levin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NKARTA, INC. | Directeur Financier/CFO | 05/07/2023 | - |
Historique de carrière de Alyssa Levin
Anciens postes connus de Alyssa Levin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Directeur Financier/CFO | - | 05/07/2023 |
| Tentarix Biotherapeutics, Inc. | Directeur des opérations | 01/01/2020 | 02/01/2022 |
| Directeur Financier/CFO | 01/01/2020 | 02/01/2022 | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Directeur Financier/CFO | 01/01/2019 | 02/01/2020 |
Formation de Alyssa Levin
| University of British Columbia | Undergraduate Degree |
| Edwards School of Business | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
Opérationnelle
| Director of Finance/CFO | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NKARTA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
| Tentarix Biotherapeutics, Inc. |
- Bourse
- Insiders
- Alyssa Levin
- Expérience
